ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $97,892,000 | -7.8% | 7,869,172 | +1.4% | 0.01% | -18.2% |
| Q3 2016 | $106,218,000 | +148.0% | 7,758,827 | +33.9% | 0.01% | +120.0% |
| Q2 2016 | $42,831,000 | +17.7% | 5,795,195 | +1.8% | 0.01% | +25.0% |
| Q1 2016 | $36,389,000 | -15.5% | 5,694,759 | -17.3% | 0.00% | -20.0% |
| Q4 2015 | $43,046,000 | +18.1% | 6,887,007 | +10.3% | 0.01% | +25.0% |
| Q3 2015 | $36,458,000 | -27.6% | 6,242,593 | +2.5% | 0.00% | -20.0% |
| Q2 2015 | $50,350,000 | +7.0% | 6,088,120 | +6.6% | 0.01% | 0.0% |
| Q1 2015 | $47,053,000 | +18.3% | 5,710,519 | -1.3% | 0.01% | +25.0% |
| Q4 2014 | $39,761,000 | +25.8% | 5,787,408 | -1.1% | 0.00% | +33.3% |
| Q3 2014 | $31,614,000 | -14.0% | 5,854,030 | +1.4% | 0.00% | -25.0% |
| Q2 2014 | $36,774,000 | -5.9% | 5,772,991 | +19.1% | 0.00% | 0.0% |
| Q1 2014 | $39,070,000 | -62.3% | 4,847,909 | -48.9% | 0.00% | -42.9% |
| Q4 2013 | $103,684,000 | +57.0% | 9,493,643 | +164.6% | 0.01% | -12.5% |
| Q3 2013 | $66,030,000 | +4.1% | 3,588,431 | -1.1% | 0.01% | 0.0% |
| Q2 2013 | $63,435,000 | – | 3,627,162 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |